#AstraZeneca
-

AstraZeneca-Bristol Myers Merger Talks Stir Doubts Over $400 Billion Pharma Deal
Reported merger talks between AstraZeneca and Bristol Myers Squibb have put a potential $400 billion pharmaceutical deal on investors’ radar.…
-

AstraZeneca Shares Drop 5.7% After Wainua Phase 3 Trial Miss
AstraZeneca lost about $24 billion in market value after Wainua failed a pivotal Phase 3 heart trial. Investors are now…